APA

Li Y., Li G., Chu Z., Hao C., Jiang Z., Chen H., Lin J., Li D., Hu B., Wang X. & Lin F. (20181024). Conversion chemotherapy with capecitabine and oxaliplatin for colorectal cancer with potentially resectable liver metastases: A phase II, open-label, single-arm study. : Journal of cancer research and therapeutics.

Chicago

Li Yong, Li Guo-Xin, Chu Zhong-Hua, Hao Chun-Yi, Jiang Zhi-Wei, Chen Huan-Qiu, Lin Jian-Jiang, Li De-Chuan, Hu Bing, Wang Xi-Shan and Lin Feng. 20181024. Conversion chemotherapy with capecitabine and oxaliplatin for colorectal cancer with potentially resectable liver metastases: A phase II, open-label, single-arm study. : Journal of cancer research and therapeutics.

Harvard

Li Y., Li G., Chu Z., Hao C., Jiang Z., Chen H., Lin J., Li D., Hu B., Wang X. and Lin F. (20181024). Conversion chemotherapy with capecitabine and oxaliplatin for colorectal cancer with potentially resectable liver metastases: A phase II, open-label, single-arm study. : Journal of cancer research and therapeutics.

MLA

Li Yong, Li Guo-Xin, Chu Zhong-Hua, Hao Chun-Yi, Jiang Zhi-Wei, Chen Huan-Qiu, Lin Jian-Jiang, Li De-Chuan, Hu Bing, Wang Xi-Shan and Lin Feng. Conversion chemotherapy with capecitabine and oxaliplatin for colorectal cancer with potentially resectable liver metastases: A phase II, open-label, single-arm study. : Journal of cancer research and therapeutics. 20181024.